Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

164 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
ABCB1 gene polymorphisms are associated with adverse reactions in fluoropyrimidine-treated colorectal cancer patients.
Gonzalez-Haba E, García MI, Cortejoso L, López-Lillo C, Barrueco N, García-Alfonso P, Alvarez S, Jiménez JL, Martín ML, Muñóz-Fernández MA, Sanjurjo M, López-Fernández LA. Gonzalez-Haba E, et al. Among authors: garcia alfonso p, garcia mi. Pharmacogenomics. 2010 Dec;11(12):1715-23. doi: 10.2217/pgs.10.159. Pharmacogenomics. 2010. PMID: 21142915
Identification of new SNPs associated with severe toxicity to capecitabine.
Pellicer M, García-González X, García MI, Robles L, Grávalos C, García-Alfonso P, Pachón V, Longo F, Martínez V, Blanco C, Iglesias I, Sanjurjo M, López-Fernández LA. Pellicer M, et al. Among authors: garcia alfonso p, garcia gonzalez x, garcia mi. Pharmacol Res. 2017 Jun;120:133-137. doi: 10.1016/j.phrs.2017.03.021. Epub 2017 Mar 27. Pharmacol Res. 2017. PMID: 28347776
Use of exome sequencing to determine the full profile of genetic variants in the fluoropyrimidine pathway in colorectal cancer patients affected by severe toxicity.
Pellicer M, García-González X, García MI, Blanco C, García-Alfonso P, Robles L, Grávalos C, Rueda D, Martínez J, Pachón V, Longo F, Martínez V, Iglesias I, Salvador S, Sanjurjo M, López-Fernández LA. Pellicer M, et al. Among authors: garcia alfonso p, garcia gonzalez x, garcia mi. Pharmacogenomics. 2017 Aug;18(13):1215-1223. doi: 10.2217/pgs-2017-0118. Epub 2017 Jul 26. Pharmacogenomics. 2017. PMID: 28745575
Clinical utility of ABCB1 genotyping for preventing toxicity in treatment with irinotecan.
Salvador-Martín S, García-González X, García MI, Blanco C, García-Alfonso P, Robles L, Grávalos C, Pachón V, Longo F, Martínez V, Sanjurjo-Sáez M, López-Fernández LA. Salvador-Martín S, et al. Among authors: garcia alfonso p, garcia gonzalez x, garcia mi. Pharmacol Res. 2018 Oct;136:133-139. doi: 10.1016/j.phrs.2018.08.026. Epub 2018 Sep 11. Pharmacol Res. 2018. PMID: 30213564
Severe toxicity to capecitabine due to a new variant at a donor splicing site in the dihydropyrimidine dehydrogenase (DPYD) gene.
García-González X, López-Tarruella S, García MI, González-Haba E, Blanco C, Salvador-Martin S, Jerez Y, Thomas F, Jarama M, Sáez MS, Martín M, López-Fernández LA. García-González X, et al. Among authors: garcia mi. Cancer Manag Res. 2018 Oct 11;10:4517-4522. doi: 10.2147/CMAR.S174470. eCollection 2018. Cancer Manag Res. 2018. PMID: 30349384 Free PMC article.
Comments on: "Clinical utility of ABCB1 genotyping for preventing toxicity in treatment with irinotecan".
Salvador-Martiín S, García-González X, García MI, Blanco C, García-Alfonso P, Robles L, Grávalos C, Pachón V, Longo F, Martínez V, Sanjurjo-Sáez M, López-Fernández LA. Salvador-Martiín S, et al. Among authors: garcia alfonso p, garcia gonzalez x, garcia mi. Pharmacol Res. 2019 Jul;145:104288. doi: 10.1016/j.phrs.2019.104288. Epub 2019 May 26. Pharmacol Res. 2019. PMID: 31141714 No abstract available.
164 results